JP Morgan has reiterated its Overweight rating on Pacs Group Inc (PACS) as of December 16, 2025. The current share price stands at $34.47.
Pacs Group Inc operates in the health care sector, focusing on post-acute healthcare facilities and services. The company, headquartered in Farmington, Utah, employs 32,433 individuals and operates approximately 314 facilities across 17 states, serving over 30,000 patients daily. The firm went public on April 11, 2024.
As of December 9, 2025, Pacs Group Inc has a market capitalization of $4.8 billion, with a price-to-earnings ratio (P/E) of 36.53 and earnings per share (EPS) of 0.80. Recent earnings reports show a positive trend, with Q2 2025 EPS at $0.45, exceeding estimates by 13.3%, and Q3 2025 EPS at $0.44, surpassing estimates by 8.7%.
Analyst consensus currently reflects 3 Strong Buy, 7 Buy, 1 Hold, with no Sell or Strong Sell ratings, indicating a general positive outlook among analysts. The move underscores JP Morgan's confidence in Pacs Group's business model despite recent market dynamics.
Investor decisions should consider a range of factors, including company fundamentals, competitive positioning, and market trends, alongside analyst opinions.